Daqing Wang

This inventor holds 34 USPTO granted patents and 23 published patent applications, plus 4 CIPO patents and 11 EPO patents, primarily in Immune Modulation. Top assignee: Idera Pharmaceuticals, Inc.. Active years: 2009-2022.

USPTO Granted Patents = 34 (Patent Applications = 23)

% Patents Active = 29.4

CIPO Patents = 4 (Patent Applications = 8)

EPO Patents = 11 (Patent Applications = 26)

Average Co-Inventor Count = 5.0

ph-index = 9

Forward Citations = 246(Granted Patents)

Location History:

Cambridge, MA (US) (2015)
Bedford, MA (US) (2009 - 2022)

Company Filing History:

34 out of 80

Idera Pharmaceuticals, Inc.

patents

Years Active: 2009-2022

Loading Chart...

Areas of Expertise:

TLR Agonists

Immune Modulation

Cancer Treatment

RNA Compounds

Checkpoint Inhibition

Oligonucleotides

Synthetic Agonists

Immunomers

Gene Expression

Toll-Like Receptors

Cancer Immunotherapy

Stabilized RNA

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11224611 - Immune modulation with TLR9 agonists for cancer treatment (2022-01-18),

2. 10835550 - Immune modulation with TLR9 agonists for cancer treatment (2020-11-17),

3. 10772907 - Immune modulation with TLR9 agonists for cancer treatment (2020-09-15),

4. 10463686 - Immune modulation with TLR9 agonists for cancer treatment (2019-11-05),

5. 10066230 - Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response (2018-09-04),

6. 10041076 - Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response (2018-08-07),

7. 9828601 - Compositions for inhibiting checkpoint gene expression and uses thereof (2017-11-28),

8. 9688993 - Toll-like receptor 9 antagonist and methods of use thereof (2017-06-27),

9. 9540651 - Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response (2017-01-10),

10. 9453228 - Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response (2016-09-27),

11. 9260719 - Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response (2016-02-16),

12. 9243050 - Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8 (2016-01-26),

13. 9206430 - Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response (2015-12-08),

14. 9096858 - Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response (2015-08-04),

15. 8853375 - Toll like receptor modulators (2014-10-07),

Title: Daqing Wang: Pioneering Inventor from Bedford, MA

Introduction: Daqing Wang is a renowned inventor based in Bedford, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Daqing Wang holds several patents in the areas of technology and healthcare, with his most recent inventions focusing on artificial intelligence and medical devices.

Career Highlights: Throughout his illustrious career, Daqing Wang has worked with top research institutions and leading companies to develop innovative solutions that have significantly impacted industries worldwide.

Collaborations: Daqing Wang has collaborated with a diverse range of experts, including scientists, engineers, and medical professionals, to bring his inventions to life and ensure their success in the market.

Conclusion: Daqing Wang's dedication to innovation and his passion for creating cutting-edge technologies have solidified his reputation as a trailblazing inventor in the field.